Edinburgh Partners’s Celgene Corp CELG Stock Holding History

Edinburgh Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$28.2M	Hold	315,906	–	–	12.91%	5
2017 Q4	$33M	Buy	315,906 +45,801	+17%	+$5.17M	8.7%	4
2017 Q3	$39.4M	Sell	270,105 -26,199	-9%	-$3.57M	9.48%	3
2017 Q2	$38.5M	Sell	296,304 -34,594	-10%	-$4.24M	10.73%	3
2017 Q1	$41.2M	Sell	330,898 -165,990	-33%	-$19.9M	9.58%	2
2016 Q4	$57.5M	Buy	496,888 +6,041	+1%	+$673K	12.1%	4
2016 Q3	$51.3M	Sell	490,847 -79,280	-14%	-$8.58M	9.54%	6
2016 Q2	$56.2M	Sell	570,127 -115,341	-17%	-$11.9M	8.53%	7
2016 Q1	$68.6M	Buy	685,468 +684,075	+49,108%	+$70.4M	7.73%	9
2015 Q4	$167K	Buy	1,393 +88	+7%	+$10.2K	0.02%	15
2015 Q3	$141K	Hold	1,305	–	–	0.01%	14
2015 Q2	$156K	Buy	1,305 +134	+11%	+$15.3K	0.02%	13
2015 Q1	$134K	Hold	1,171	–	–	0.02%	13
2014 Q4	$133K	Buy	1,171 +277	+31%	+$29.2K	0.01%	11
2014 Q3	$84K	Hold	894	–	–	0.01%	20
2014 Q2	$79K	Hold	894	–	–	0.01%	25
2014 Q1	$62K	Hold	894	–	–	0.01%	34
2013 Q4	$76K	Hold	894	–	–	0.01%	21
2013 Q3	$69K	Hold	894	–	–	0.01%	21
2013 Q2	$53K	Buy	+894	New	+$53.8K	﹤0.01%	23

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Edinburgh Partners's CELG Position: Q1 2018 in Review

Edinburgh Partners held its Celgene Corp (CELG) position steady in Q1 2018 at 315,906 shares worth $28.2M. The position accounts for 12.91% of the portfolio, ranked #5.

Edinburgh Partners first reported a position in CELG in Q2 2013 and has held it in 20 quarters since. The position peaked at $68.6M in Q1 2016. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Edinburgh Partners held 315,906 shares of Celgene Corp worth $28.2M as of Q1 2018.
Edinburgh Partners left its Celgene Corp share count unchanged in Q1 2018.
Celgene Corp made up 12.91% of Edinburgh Partners's portfolio in Q1 2018, its #5 holding.
Edinburgh Partners first reported a position in Celgene Corp in Q2 2013 and has held it in 20 quarters since.
Edinburgh Partners's Celgene Corp position peaked at $68.6M in Q1 2016.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Edinburgh Partners's 13F filing for Q1 2018, filed 10 May 2018.